The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Barbara Fingleton

Department of Cancer Biology

Vanderbilt University Medical Center

Nashville

Tennessee 37232

USA

[email]@vanderbilt.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA. 2006 - 2008
  • Vanderbilt University Medical Center, Department of Cancer Biology, 736 PRB 23rd and Pierce Avenues, Nashville, USA. 2003

References

  1. MMPs as therapeutic targets--still a viable option?. Fingleton, B. Semin. Cell Dev. Biol. (2008) [Pubmed]
  2. Loss of functional Fas ligand enhances intestinal tumorigenesis in the Min mouse model. Fingleton, B., Carter, K.J., Matrisian, L.M. Cancer Res. (2007) [Pubmed]
  3. Matrix metalloproteinases as valid clinical targets. Fingleton, B. Curr. Pharm. Des. (2007) [Pubmed]
  4. A rat monoclonal antibody that recognizes pro- and active MMP-7 indicates polarized expression in vivo. Fingleton, B., Powell, W.C., Crawford, H.C., Couchman, J.R., Matrisian, L.M. Hybridoma. (Larchmt) (2007) [Pubmed]
  5. Molecular targets in metastasis: lessons from genomic approaches. Fingleton, B. Cancer. Genomics. Proteomics (2007) [Pubmed]
  6. Matrix metalloproteinases: roles in cancer and metastasis. Fingleton, B. Front. Biosci. (2006) [Pubmed]
  7. Matrix metalloproteinase inhibitors for cancer therapy:the current situation and future prospects. Fingleton, B. Expert Opin. Ther. Targets (2003) [Pubmed]
  8. CMT-3. CollaGenex. Fingleton, B. Curr. Opin. Investig. Drugs (2003) [Pubmed]
 
WikiGenes - Universities